nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—CYP3A4—Imiquimod—skin cancer	0.114	0.292	CbGbCtD
Levonorgestrel—CYP3A4—Temozolomide—skin cancer	0.114	0.292	CbGbCtD
Levonorgestrel—CYP3A4—Vismodegib—skin cancer	0.0787	0.202	CbGbCtD
Levonorgestrel—CYP3A4—Vemurafenib—skin cancer	0.0622	0.16	CbGbCtD
Levonorgestrel—AR—scrotum—skin cancer	0.0288	0.198	CbGeAlD
Levonorgestrel—CYP3A4—Docetaxel—skin cancer	0.0214	0.0548	CbGbCtD
Levonorgestrel—SHBG—hindlimb—skin cancer	0.0137	0.0938	CbGeAlD
Levonorgestrel—AR—penis—skin cancer	0.013	0.0892	CbGeAlD
Levonorgestrel—SRD5A1—female reproductive system—skin cancer	0.00648	0.0445	CbGeAlD
Levonorgestrel—PGR—blood vessel—skin cancer	0.00587	0.0404	CbGeAlD
Levonorgestrel—SRD5A1—head—skin cancer	0.00541	0.0372	CbGeAlD
Levonorgestrel—SHBG—neck—skin cancer	0.00466	0.0321	CbGeAlD
Levonorgestrel—ESR1—blood vessel—skin cancer	0.00459	0.0316	CbGeAlD
Levonorgestrel—PGR—nipple—skin cancer	0.00425	0.0292	CbGeAlD
Levonorgestrel—AR—nipple—skin cancer	0.00338	0.0233	CbGeAlD
Levonorgestrel—SHBG—connective tissue—skin cancer	0.00334	0.023	CbGeAlD
Levonorgestrel—ESR1—neck—skin cancer	0.00329	0.0226	CbGeAlD
Levonorgestrel—PGR—connective tissue—skin cancer	0.00301	0.0207	CbGeAlD
Levonorgestrel—PGR—epithelium—skin cancer	0.00286	0.0197	CbGeAlD
Levonorgestrel—CYP19A1—connective tissue—skin cancer	0.00271	0.0186	CbGeAlD
Levonorgestrel—AR—connective tissue—skin cancer	0.0024	0.0165	CbGeAlD
Levonorgestrel—SHBG—female reproductive system—skin cancer	0.00236	0.0162	CbGeAlD
Levonorgestrel—ESR1—connective tissue—skin cancer	0.00236	0.0162	CbGeAlD
Levonorgestrel—AR—epithelium—skin cancer	0.00228	0.0157	CbGeAlD
Levonorgestrel—ESR1—epithelium—skin cancer	0.00224	0.0154	CbGeAlD
Levonorgestrel—PGR—lymphoid tissue—skin cancer	0.0022	0.0151	CbGeAlD
Levonorgestrel—AR—skin of body—skin cancer	0.00217	0.0149	CbGeAlD
Levonorgestrel—PGR—female reproductive system—skin cancer	0.00212	0.0146	CbGeAlD
Levonorgestrel—AR—mammalian vulva—skin cancer	0.00198	0.0136	CbGeAlD
Levonorgestrel—CYP19A1—female reproductive system—skin cancer	0.00191	0.0131	CbGeAlD
Levonorgestrel—PGR—head—skin cancer	0.00177	0.0122	CbGeAlD
Levonorgestrel—AR—lymphoid tissue—skin cancer	0.00175	0.0121	CbGeAlD
Levonorgestrel—ESR1—lymphoid tissue—skin cancer	0.00172	0.0118	CbGeAlD
Levonorgestrel—AR—female reproductive system—skin cancer	0.00169	0.0116	CbGeAlD
Levonorgestrel—ESR1—female reproductive system—skin cancer	0.00166	0.0114	CbGeAlD
Levonorgestrel—CYP19A1—head—skin cancer	0.0016	0.011	CbGeAlD
Levonorgestrel—AR—head—skin cancer	0.00141	0.00972	CbGeAlD
Levonorgestrel—ESR1—head—skin cancer	0.00139	0.00954	CbGeAlD
Levonorgestrel—PGR—lymph node—skin cancer	0.00124	0.00854	CbGeAlD
Levonorgestrel—CYP19A1—lymph node—skin cancer	0.00112	0.00768	CbGeAlD
Levonorgestrel—AR—lymph node—skin cancer	0.00099	0.0068	CbGeAlD
Levonorgestrel—ESR1—lymph node—skin cancer	0.000972	0.00668	CbGeAlD
Levonorgestrel—CYP3A4—female reproductive system—skin cancer	0.000927	0.00637	CbGeAlD
Levonorgestrel—Depression—Temozolomide—skin cancer	0.000733	0.00158	CcSEcCtD
Levonorgestrel—Body temperature increased—Vemurafenib—skin cancer	0.000725	0.00156	CcSEcCtD
Levonorgestrel—Pharyngitis—Dactinomycin—skin cancer	0.000724	0.00156	CcSEcCtD
Levonorgestrel—Urinary tract infection—Temozolomide—skin cancer	0.000715	0.00154	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000713	0.00153	CcSEcCtD
Levonorgestrel—Insomnia—Imiquimod—skin cancer	0.000708	0.00152	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000706	0.00152	CcSEcCtD
Levonorgestrel—Dyspnoea—Imiquimod—skin cancer	0.000698	0.0015	CcSEcCtD
Levonorgestrel—Somnolence—Imiquimod—skin cancer	0.000696	0.0015	CcSEcCtD
Levonorgestrel—Alopecia—Bleomycin—skin cancer	0.000691	0.00149	CcSEcCtD
Levonorgestrel—Erythema multiforme—Dactinomycin—skin cancer	0.00069	0.00148	CcSEcCtD
Levonorgestrel—Sinusitis—Temozolomide—skin cancer	0.00069	0.00148	CcSEcCtD
Levonorgestrel—Dyspepsia—Imiquimod—skin cancer	0.000689	0.00148	CcSEcCtD
Levonorgestrel—Pneumonia—Fluorouracil—skin cancer	0.000681	0.00147	CcSEcCtD
Levonorgestrel—Erythema—Bleomycin—skin cancer	0.000681	0.00147	CcSEcCtD
Levonorgestrel—Decreased appetite—Imiquimod—skin cancer	0.00068	0.00146	CcSEcCtD
Levonorgestrel—Infestation NOS—Fluorouracil—skin cancer	0.000677	0.00146	CcSEcCtD
Levonorgestrel—Infestation—Fluorouracil—skin cancer	0.000677	0.00146	CcSEcCtD
Levonorgestrel—Hypersensitivity—Vemurafenib—skin cancer	0.000676	0.00145	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Imiquimod—skin cancer	0.000676	0.00145	CcSEcCtD
Levonorgestrel—Fatigue—Imiquimod—skin cancer	0.000675	0.00145	CcSEcCtD
Levonorgestrel—Pain—Imiquimod—skin cancer	0.000669	0.00144	CcSEcCtD
Levonorgestrel—Haemoglobin—Temozolomide—skin cancer	0.000663	0.00143	CcSEcCtD
Levonorgestrel—Haemorrhage—Temozolomide—skin cancer	0.00066	0.00142	CcSEcCtD
Levonorgestrel—Urinary tract infection—Fluorouracil—skin cancer	0.000659	0.00142	CcSEcCtD
Levonorgestrel—Asthenia—Vemurafenib—skin cancer	0.000658	0.00142	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Temozolomide—skin cancer	0.000657	0.00141	CcSEcCtD
Levonorgestrel—Pharyngitis—Temozolomide—skin cancer	0.000655	0.00141	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Temozolomide—skin cancer	0.000652	0.0014	CcSEcCtD
Levonorgestrel—Pruritus—Vemurafenib—skin cancer	0.000649	0.0014	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Temozolomide—skin cancer	0.000649	0.0014	CcSEcCtD
Levonorgestrel—Urethral disorder—Temozolomide—skin cancer	0.000647	0.00139	CcSEcCtD
Levonorgestrel—Alopecia—Dactinomycin—skin cancer	0.000645	0.00139	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Imiquimod—skin cancer	0.00064	0.00138	CcSEcCtD
Levonorgestrel—Visual impairment—Temozolomide—skin cancer	0.000636	0.00137	CcSEcCtD
Levonorgestrel—Sinusitis—Fluorouracil—skin cancer	0.000636	0.00137	CcSEcCtD
Levonorgestrel—Erythema—Dactinomycin—skin cancer	0.000635	0.00137	CcSEcCtD
Levonorgestrel—Pain in extremity—Docetaxel—skin cancer	0.000635	0.00136	CcSEcCtD
Levonorgestrel—Anaemia—Bleomycin—skin cancer	0.00063	0.00135	CcSEcCtD
Levonorgestrel—Diarrhoea—Vemurafenib—skin cancer	0.000628	0.00135	CcSEcCtD
Levonorgestrel—Migraine—Docetaxel—skin cancer	0.000625	0.00134	CcSEcCtD
Levonorgestrel—Erythema multiforme—Temozolomide—skin cancer	0.000624	0.00134	CcSEcCtD
Levonorgestrel—Urticaria—Imiquimod—skin cancer	0.000622	0.00134	CcSEcCtD
Levonorgestrel—Abdominal pain—Imiquimod—skin cancer	0.000619	0.00133	CcSEcCtD
Levonorgestrel—Body temperature increased—Imiquimod—skin cancer	0.000619	0.00133	CcSEcCtD
Levonorgestrel—Eye disorder—Temozolomide—skin cancer	0.000617	0.00133	CcSEcCtD
Levonorgestrel—Cardiac disorder—Temozolomide—skin cancer	0.000613	0.00132	CcSEcCtD
Levonorgestrel—Haemoglobin—Fluorouracil—skin cancer	0.000611	0.00131	CcSEcCtD
Levonorgestrel—Rhinitis—Fluorouracil—skin cancer	0.00061	0.00131	CcSEcCtD
Levonorgestrel—Haemorrhage—Fluorouracil—skin cancer	0.000608	0.00131	CcSEcCtD
Levonorgestrel—Dizziness—Vemurafenib—skin cancer	0.000607	0.00131	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Fluorouracil—skin cancer	0.000605	0.0013	CcSEcCtD
Levonorgestrel—Pharyngitis—Fluorouracil—skin cancer	0.000604	0.0013	CcSEcCtD
Levonorgestrel—Immune system disorder—Temozolomide—skin cancer	0.000596	0.00128	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Temozolomide—skin cancer	0.000595	0.00128	CcSEcCtD
Levonorgestrel—Cough—Bleomycin—skin cancer	0.000594	0.00128	CcSEcCtD
Levonorgestrel—Anaemia—Dactinomycin—skin cancer	0.000587	0.00126	CcSEcCtD
Levonorgestrel—Vomiting—Vemurafenib—skin cancer	0.000583	0.00125	CcSEcCtD
Levonorgestrel—Alopecia—Temozolomide—skin cancer	0.000583	0.00125	CcSEcCtD
Levonorgestrel—Dry skin—Docetaxel—skin cancer	0.000582	0.00125	CcSEcCtD
Levonorgestrel—Myalgia—Bleomycin—skin cancer	0.00058	0.00125	CcSEcCtD
Levonorgestrel—Chest pain—Bleomycin—skin cancer	0.00058	0.00125	CcSEcCtD
Levonorgestrel—Rash—Vemurafenib—skin cancer	0.000579	0.00124	CcSEcCtD
Levonorgestrel—Mental disorder—Temozolomide—skin cancer	0.000578	0.00124	CcSEcCtD
Levonorgestrel—Dermatitis—Vemurafenib—skin cancer	0.000578	0.00124	CcSEcCtD
Levonorgestrel—Hypersensitivity—Imiquimod—skin cancer	0.000577	0.00124	CcSEcCtD
Levonorgestrel—Headache—Vemurafenib—skin cancer	0.000575	0.00124	CcSEcCtD
Levonorgestrel—Erythema—Temozolomide—skin cancer	0.000575	0.00124	CcSEcCtD
Levonorgestrel—Malnutrition—Temozolomide—skin cancer	0.000575	0.00124	CcSEcCtD
Levonorgestrel—Breast disorder—Docetaxel—skin cancer	0.000573	0.00123	CcSEcCtD
Levonorgestrel—Discomfort—Bleomycin—skin cancer	0.000573	0.00123	CcSEcCtD
Levonorgestrel—Asthenia—Imiquimod—skin cancer	0.000561	0.00121	CcSEcCtD
Levonorgestrel—Oedema—Bleomycin—skin cancer	0.000556	0.0012	CcSEcCtD
Levonorgestrel—Back pain—Temozolomide—skin cancer	0.000556	0.0012	CcSEcCtD
Levonorgestrel—Pruritus—Imiquimod—skin cancer	0.000554	0.00119	CcSEcCtD
Levonorgestrel—Infection—Bleomycin—skin cancer	0.000552	0.00119	CcSEcCtD
Levonorgestrel—Nausea—Vemurafenib—skin cancer	0.000545	0.00117	CcSEcCtD
Levonorgestrel—Arrhythmia—Fluorouracil—skin cancer	0.000543	0.00117	CcSEcCtD
Levonorgestrel—Myalgia—Dactinomycin—skin cancer	0.000541	0.00116	CcSEcCtD
Levonorgestrel—Alopecia—Fluorouracil—skin cancer	0.000537	0.00116	CcSEcCtD
Levonorgestrel—Diarrhoea—Imiquimod—skin cancer	0.000535	0.00115	CcSEcCtD
Levonorgestrel—Discomfort—Dactinomycin—skin cancer	0.000534	0.00115	CcSEcCtD
Levonorgestrel—Anaemia—Temozolomide—skin cancer	0.000531	0.00114	CcSEcCtD
Levonorgestrel—Anorexia—Bleomycin—skin cancer	0.00053	0.00114	CcSEcCtD
Levonorgestrel—Erythema—Fluorouracil—skin cancer	0.000529	0.00114	CcSEcCtD
Levonorgestrel—Angioedema—Temozolomide—skin cancer	0.000525	0.00113	CcSEcCtD
Levonorgestrel—Oedema—Dactinomycin—skin cancer	0.000519	0.00112	CcSEcCtD
Levonorgestrel—Dizziness—Imiquimod—skin cancer	0.000517	0.00111	CcSEcCtD
Levonorgestrel—Vertigo—Temozolomide—skin cancer	0.000516	0.00111	CcSEcCtD
Levonorgestrel—Infection—Dactinomycin—skin cancer	0.000515	0.00111	CcSEcCtD
Levonorgestrel—Palpitations—Temozolomide—skin cancer	0.000508	0.00109	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000507	0.00109	CcSEcCtD
Levonorgestrel—Cough—Temozolomide—skin cancer	0.000501	0.00108	CcSEcCtD
Levonorgestrel—Weight increased—Docetaxel—skin cancer	0.000499	0.00107	CcSEcCtD
Levonorgestrel—Vomiting—Imiquimod—skin cancer	0.000498	0.00107	CcSEcCtD
Levonorgestrel—Weight decreased—Docetaxel—skin cancer	0.000496	0.00107	CcSEcCtD
Levonorgestrel—Hypertension—Temozolomide—skin cancer	0.000496	0.00107	CcSEcCtD
Levonorgestrel—Dyspnoea—Bleomycin—skin cancer	0.000496	0.00107	CcSEcCtD
Levonorgestrel—Anorexia—Dactinomycin—skin cancer	0.000494	0.00106	CcSEcCtD
Levonorgestrel—Rash—Imiquimod—skin cancer	0.000493	0.00106	CcSEcCtD
Levonorgestrel—Dermatitis—Imiquimod—skin cancer	0.000493	0.00106	CcSEcCtD
Levonorgestrel—Pneumonia—Docetaxel—skin cancer	0.000492	0.00106	CcSEcCtD
Levonorgestrel—Headache—Imiquimod—skin cancer	0.00049	0.00105	CcSEcCtD
Levonorgestrel—Anaemia—Fluorouracil—skin cancer	0.000489	0.00105	CcSEcCtD
Levonorgestrel—Myalgia—Temozolomide—skin cancer	0.000489	0.00105	CcSEcCtD
Levonorgestrel—Infestation NOS—Docetaxel—skin cancer	0.000489	0.00105	CcSEcCtD
Levonorgestrel—Infestation—Docetaxel—skin cancer	0.000489	0.00105	CcSEcCtD
Levonorgestrel—Anxiety—Temozolomide—skin cancer	0.000488	0.00105	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000486	0.00104	CcSEcCtD
Levonorgestrel—Discomfort—Temozolomide—skin cancer	0.000483	0.00104	CcSEcCtD
Levonorgestrel—Decreased appetite—Bleomycin—skin cancer	0.000483	0.00104	CcSEcCtD
Levonorgestrel—Pain—Bleomycin—skin cancer	0.000475	0.00102	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000472	0.00102	CcSEcCtD
Levonorgestrel—Oedema—Temozolomide—skin cancer	0.000469	0.00101	CcSEcCtD
Levonorgestrel—Infection—Temozolomide—skin cancer	0.000466	0.001	CcSEcCtD
Levonorgestrel—Nausea—Imiquimod—skin cancer	0.000465	0.001	CcSEcCtD
Levonorgestrel—Nervous system disorder—Temozolomide—skin cancer	0.00046	0.000989	CcSEcCtD
Levonorgestrel—Skin disorder—Temozolomide—skin cancer	0.000456	0.00098	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Temozolomide—skin cancer	0.000453	0.000975	CcSEcCtD
Levonorgestrel—Chest pain—Fluorouracil—skin cancer	0.000451	0.000969	CcSEcCtD
Levonorgestrel—Myalgia—Fluorouracil—skin cancer	0.000451	0.000969	CcSEcCtD
Levonorgestrel—Decreased appetite—Dactinomycin—skin cancer	0.000451	0.000969	CcSEcCtD
Levonorgestrel—Fatigue—Dactinomycin—skin cancer	0.000447	0.000961	CcSEcCtD
Levonorgestrel—Anorexia—Temozolomide—skin cancer	0.000447	0.000961	CcSEcCtD
Levonorgestrel—Discomfort—Fluorouracil—skin cancer	0.000445	0.000958	CcSEcCtD
Levonorgestrel—Pain—Dactinomycin—skin cancer	0.000443	0.000954	CcSEcCtD
Levonorgestrel—Urticaria—Bleomycin—skin cancer	0.000442	0.00095	CcSEcCtD
Levonorgestrel—Haemoglobin—Docetaxel—skin cancer	0.000441	0.000949	CcSEcCtD
Levonorgestrel—Rhinitis—Docetaxel—skin cancer	0.00044	0.000947	CcSEcCtD
Levonorgestrel—Body temperature increased—Bleomycin—skin cancer	0.000439	0.000945	CcSEcCtD
Levonorgestrel—Haemorrhage—Docetaxel—skin cancer	0.000439	0.000944	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Docetaxel—skin cancer	0.000437	0.000939	CcSEcCtD
Levonorgestrel—Pharyngitis—Docetaxel—skin cancer	0.000436	0.000937	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Docetaxel—skin cancer	0.000434	0.000932	CcSEcCtD
Levonorgestrel—Oedema—Fluorouracil—skin cancer	0.000432	0.000929	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Docetaxel—skin cancer	0.000431	0.000928	CcSEcCtD
Levonorgestrel—Urethral disorder—Docetaxel—skin cancer	0.00043	0.000926	CcSEcCtD
Levonorgestrel—Infection—Fluorouracil—skin cancer	0.000429	0.000923	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000427	0.000919	CcSEcCtD
Levonorgestrel—Insomnia—Temozolomide—skin cancer	0.000424	0.000912	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Dactinomycin—skin cancer	0.000424	0.000912	CcSEcCtD
Levonorgestrel—Nervous system disorder—Fluorouracil—skin cancer	0.000424	0.000911	CcSEcCtD
Levonorgestrel—Visual impairment—Docetaxel—skin cancer	0.000423	0.00091	CcSEcCtD
Levonorgestrel—Dyspnoea—Temozolomide—skin cancer	0.000418	0.000899	CcSEcCtD
Levonorgestrel—Somnolence—Temozolomide—skin cancer	0.000417	0.000897	CcSEcCtD
Levonorgestrel—Erythema multiforme—Docetaxel—skin cancer	0.000415	0.000893	CcSEcCtD
Levonorgestrel—Dyspepsia—Temozolomide—skin cancer	0.000413	0.000888	CcSEcCtD
Levonorgestrel—Anorexia—Fluorouracil—skin cancer	0.000412	0.000886	CcSEcCtD
Levonorgestrel—Eye disorder—Docetaxel—skin cancer	0.00041	0.000882	CcSEcCtD
Levonorgestrel—Body temperature increased—Dactinomycin—skin cancer	0.00041	0.000882	CcSEcCtD
Levonorgestrel—Abdominal pain—Dactinomycin—skin cancer	0.00041	0.000882	CcSEcCtD
Levonorgestrel—Hypersensitivity—Bleomycin—skin cancer	0.00041	0.000881	CcSEcCtD
Levonorgestrel—Decreased appetite—Temozolomide—skin cancer	0.000408	0.000877	CcSEcCtD
Levonorgestrel—Cardiac disorder—Docetaxel—skin cancer	0.000407	0.000876	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Temozolomide—skin cancer	0.000405	0.000871	CcSEcCtD
Levonorgestrel—Fatigue—Temozolomide—skin cancer	0.000404	0.00087	CcSEcCtD
Levonorgestrel—Pain—Temozolomide—skin cancer	0.000401	0.000863	CcSEcCtD
Levonorgestrel—Constipation—Temozolomide—skin cancer	0.000401	0.000863	CcSEcCtD
Levonorgestrel—Asthenia—Bleomycin—skin cancer	0.000399	0.000858	CcSEcCtD
Levonorgestrel—Immune system disorder—Docetaxel—skin cancer	0.000396	0.000853	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Docetaxel—skin cancer	0.000396	0.000851	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000394	0.000847	CcSEcCtD
Levonorgestrel—Pruritus—Bleomycin—skin cancer	0.000393	0.000846	CcSEcCtD
Levonorgestrel—Arrhythmia—Docetaxel—skin cancer	0.000392	0.000843	CcSEcCtD
Levonorgestrel—Insomnia—Fluorouracil—skin cancer	0.000391	0.000841	CcSEcCtD
Levonorgestrel—Alopecia—Docetaxel—skin cancer	0.000388	0.000834	CcSEcCtD
Levonorgestrel—Dyspnoea—Fluorouracil—skin cancer	0.000385	0.000829	CcSEcCtD
Levonorgestrel—Mental disorder—Docetaxel—skin cancer	0.000385	0.000827	CcSEcCtD
Levonorgestrel—Somnolence—Fluorouracil—skin cancer	0.000384	0.000826	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Temozolomide—skin cancer	0.000383	0.000825	CcSEcCtD
Levonorgestrel—Erythema—Docetaxel—skin cancer	0.000382	0.000822	CcSEcCtD
Levonorgestrel—Malnutrition—Docetaxel—skin cancer	0.000382	0.000822	CcSEcCtD
Levonorgestrel—Hypersensitivity—Dactinomycin—skin cancer	0.000382	0.000822	CcSEcCtD
Levonorgestrel—Dyspepsia—Fluorouracil—skin cancer	0.00038	0.000818	CcSEcCtD
Levonorgestrel—Decreased appetite—Fluorouracil—skin cancer	0.000376	0.000808	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000373	0.000802	CcSEcCtD
Levonorgestrel—Urticaria—Temozolomide—skin cancer	0.000373	0.000801	CcSEcCtD
Levonorgestrel—Asthenia—Dactinomycin—skin cancer	0.000372	0.0008	CcSEcCtD
Levonorgestrel—Abdominal pain—Temozolomide—skin cancer	0.000371	0.000797	CcSEcCtD
Levonorgestrel—Body temperature increased—Temozolomide—skin cancer	0.000371	0.000797	CcSEcCtD
Levonorgestrel—Back pain—Docetaxel—skin cancer	0.00037	0.000795	CcSEcCtD
Levonorgestrel—Pain—Fluorouracil—skin cancer	0.00037	0.000795	CcSEcCtD
Levonorgestrel—Muscle spasms—Docetaxel—skin cancer	0.000367	0.00079	CcSEcCtD
Levonorgestrel—Diarrhoea—Dactinomycin—skin cancer	0.000355	0.000763	CcSEcCtD
Levonorgestrel—Vomiting—Bleomycin—skin cancer	0.000353	0.00076	CcSEcCtD
Levonorgestrel—Anaemia—Docetaxel—skin cancer	0.000353	0.00076	CcSEcCtD
Levonorgestrel—Rash—Bleomycin—skin cancer	0.000351	0.000754	CcSEcCtD
Levonorgestrel—Dermatitis—Bleomycin—skin cancer	0.00035	0.000753	CcSEcCtD
Levonorgestrel—Hypersensitivity—Temozolomide—skin cancer	0.000346	0.000743	CcSEcCtD
Levonorgestrel—Urticaria—Fluorouracil—skin cancer	0.000343	0.000738	CcSEcCtD
Levonorgestrel—Syncope—Docetaxel—skin cancer	0.000343	0.000737	CcSEcCtD
Levonorgestrel—Body temperature increased—Fluorouracil—skin cancer	0.000342	0.000735	CcSEcCtD
Levonorgestrel—Palpitations—Docetaxel—skin cancer	0.000338	0.000726	CcSEcCtD
Levonorgestrel—Asthenia—Temozolomide—skin cancer	0.000336	0.000724	CcSEcCtD
Levonorgestrel—Loss of consciousness—Docetaxel—skin cancer	0.000336	0.000722	CcSEcCtD
Levonorgestrel—Cough—Docetaxel—skin cancer	0.000333	0.000717	CcSEcCtD
Levonorgestrel—Pruritus—Temozolomide—skin cancer	0.000332	0.000714	CcSEcCtD
Levonorgestrel—Nausea—Bleomycin—skin cancer	0.00033	0.00071	CcSEcCtD
Levonorgestrel—Hypertension—Docetaxel—skin cancer	0.00033	0.00071	CcSEcCtD
Levonorgestrel—Vomiting—Dactinomycin—skin cancer	0.00033	0.000709	CcSEcCtD
Levonorgestrel—Rash—Dactinomycin—skin cancer	0.000327	0.000703	CcSEcCtD
Levonorgestrel—Myalgia—Docetaxel—skin cancer	0.000325	0.0007	CcSEcCtD
Levonorgestrel—Chest pain—Docetaxel—skin cancer	0.000325	0.0007	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000323	0.000695	CcSEcCtD
Levonorgestrel—Diarrhoea—Temozolomide—skin cancer	0.000321	0.00069	CcSEcCtD
Levonorgestrel—Hypersensitivity—Fluorouracil—skin cancer	0.000318	0.000685	CcSEcCtD
Levonorgestrel—Oedema—Docetaxel—skin cancer	0.000312	0.000671	CcSEcCtD
Levonorgestrel—Dizziness—Temozolomide—skin cancer	0.00031	0.000667	CcSEcCtD
Levonorgestrel—Infection—Docetaxel—skin cancer	0.00031	0.000666	CcSEcCtD
Levonorgestrel—Nausea—Dactinomycin—skin cancer	0.000308	0.000662	CcSEcCtD
Levonorgestrel—Shock—Docetaxel—skin cancer	0.000307	0.00066	CcSEcCtD
Levonorgestrel—Nervous system disorder—Docetaxel—skin cancer	0.000306	0.000658	CcSEcCtD
Levonorgestrel—Pruritus—Fluorouracil—skin cancer	0.000306	0.000658	CcSEcCtD
Levonorgestrel—Skin disorder—Docetaxel—skin cancer	0.000303	0.000652	CcSEcCtD
Levonorgestrel—Vomiting—Temozolomide—skin cancer	0.000298	0.000641	CcSEcCtD
Levonorgestrel—Anorexia—Docetaxel—skin cancer	0.000297	0.000639	CcSEcCtD
Levonorgestrel—Rash—Temozolomide—skin cancer	0.000296	0.000636	CcSEcCtD
Levonorgestrel—Diarrhoea—Fluorouracil—skin cancer	0.000296	0.000636	CcSEcCtD
Levonorgestrel—Dermatitis—Temozolomide—skin cancer	0.000295	0.000635	CcSEcCtD
Levonorgestrel—Headache—Temozolomide—skin cancer	0.000294	0.000632	CcSEcCtD
Levonorgestrel—Dizziness—Fluorouracil—skin cancer	0.000286	0.000615	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000284	0.000611	CcSEcCtD
Levonorgestrel—Insomnia—Docetaxel—skin cancer	0.000282	0.000607	CcSEcCtD
Levonorgestrel—Nausea—Temozolomide—skin cancer	0.000279	0.000599	CcSEcCtD
Levonorgestrel—Dyspnoea—Docetaxel—skin cancer	0.000278	0.000598	CcSEcCtD
Levonorgestrel—Somnolence—Docetaxel—skin cancer	0.000277	0.000596	CcSEcCtD
Levonorgestrel—Vomiting—Fluorouracil—skin cancer	0.000275	0.000591	CcSEcCtD
Levonorgestrel—Dyspepsia—Docetaxel—skin cancer	0.000275	0.00059	CcSEcCtD
Levonorgestrel—Rash—Fluorouracil—skin cancer	0.000272	0.000586	CcSEcCtD
Levonorgestrel—Dermatitis—Fluorouracil—skin cancer	0.000272	0.000585	CcSEcCtD
Levonorgestrel—Decreased appetite—Docetaxel—skin cancer	0.000271	0.000583	CcSEcCtD
Levonorgestrel—Headache—Fluorouracil—skin cancer	0.000271	0.000582	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Docetaxel—skin cancer	0.000269	0.000579	CcSEcCtD
Levonorgestrel—Fatigue—Docetaxel—skin cancer	0.000269	0.000578	CcSEcCtD
Levonorgestrel—Constipation—Docetaxel—skin cancer	0.000267	0.000574	CcSEcCtD
Levonorgestrel—Pain—Docetaxel—skin cancer	0.000267	0.000574	CcSEcCtD
Levonorgestrel—Nausea—Fluorouracil—skin cancer	0.000257	0.000552	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Docetaxel—skin cancer	0.000255	0.000549	CcSEcCtD
Levonorgestrel—Body temperature increased—Docetaxel—skin cancer	0.000247	0.00053	CcSEcCtD
Levonorgestrel—Abdominal pain—Docetaxel—skin cancer	0.000247	0.00053	CcSEcCtD
Levonorgestrel—Hypersensitivity—Docetaxel—skin cancer	0.00023	0.000494	CcSEcCtD
Levonorgestrel—Asthenia—Docetaxel—skin cancer	0.000224	0.000481	CcSEcCtD
Levonorgestrel—Pruritus—Docetaxel—skin cancer	0.000221	0.000475	CcSEcCtD
Levonorgestrel—Diarrhoea—Docetaxel—skin cancer	0.000213	0.000459	CcSEcCtD
Levonorgestrel—Dizziness—Docetaxel—skin cancer	0.000206	0.000444	CcSEcCtD
Levonorgestrel—Vomiting—Docetaxel—skin cancer	0.000198	0.000427	CcSEcCtD
Levonorgestrel—Rash—Docetaxel—skin cancer	0.000197	0.000423	CcSEcCtD
Levonorgestrel—Dermatitis—Docetaxel—skin cancer	0.000196	0.000423	CcSEcCtD
Levonorgestrel—Headache—Docetaxel—skin cancer	0.000195	0.00042	CcSEcCtD
Levonorgestrel—Nausea—Docetaxel—skin cancer	0.000185	0.000398	CcSEcCtD
